Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Somatogen (SMTG) -- Ignore unavailable to you. Want to Upgrade?

To: Ron Sigourney who wrote (350)	1/1/1998 1:51:00 PM
From: Bharat H. Barai	Read Replies (2) \| Respond to of 442

Not so happy new year for Somatogen stockholders. Suspect the tax related selling was responsible for the Dec. slaughter. Tried to call Somatogen corporate office when it dipped around 4, but the recording stated the Company was closed for Holidays till Jan. 5, 1998. Had talked to nanita in 2nd week Dec. 1997. She stated that data from Cardio Pulmonary bypass study were being analysed and results may be announced early next year. With stock trading around 4.43, it is hard to believe that this stock will rise from the ashes. It is impossible to say what the market will do. Spyglass has gone from 154 to 10 (split adjusted) and US air has gone from 4 to 63. Somatogen is a single research product company with no revenues or profits at this time. I still believe, scientifically they have THE BEST Natural Hemoglobin substitute, a genetically engineered Hb as good or better than Natural Hb. Does Medicine need such a product? Absolutely yes. So why the stock in dumpster? I have patience and am willing to ride it out. In fact I bought some more yesteray. All my scientific and Medical back ground, tour of the facility with their scientists and talks with the management; tells me that this will be a very successful product, as and when it is introduced. It may take couple more years. It takes lot of courage to make such a statement. Some might think this is crazy, almost cultish! If one is willing to sit out and put this much money as HIGH but scientifically well calculated risk endevour, this may become one of the most spectacularly rewarding risk. Others who are not as willing, may wait till the trial results are announced, Corporate partner is found and FDA approves the product. Somatogen's story will unfold for years with next generation and longer circulating Hemoglobin products being introduced over few years. Difficult to make a case in such tough situation, but that is my honest personal opinion, based on scientific analysis and medical need/usage. But I could be wrong! B.H. Barai MD Hematologist